- Report
- October 2025
- 125 Pages
Global
From €5267EUR$5,950USD£4,560GBP
- Report
- April 2025
- 197 Pages
Global
From €3984EUR$4,500USD£3,449GBP
- Report
- October 2025
Global
From €4338EUR$4,900USD£3,756GBP
- Report
- June 2025
- 100 Pages
Global
From €4338EUR$4,900USD£3,756GBP
- Report
- January 2026
- 220 Pages
Global
From €5179EUR$5,850USD£4,484GBP
- Report
- January 2026
- 354 Pages
Global
From €5179EUR$5,850USD£4,484GBP
- Report
- January 2026
- 196 Pages
Global
From €5179EUR$5,850USD£4,484GBP
- Report
- January 2026
- 173 Pages
Global
From €5179EUR$5,850USD£4,484GBP
- Report
- January 2026
- 162 Pages
Global
From €5179EUR$5,850USD£4,484GBP
- Report
- January 2026
- 184 Pages
Global
From €5179EUR$5,850USD£4,484GBP
- Report
- November 2025
- 193 Pages
Global
From €3487EUR$3,939USD£3,019GBP
- Report
- August 2025
- 192 Pages
Global
From €3487EUR$3,939USD£3,019GBP
- Report
- October 2025
- 250 Pages
Global
From €3975EUR$4,490USD£3,441GBP
- Report
- November 2025
- 200 Pages
Global
From €7038EUR$7,950USD£6,093GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2656EUR$3,000USD£2,299GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1771EUR$2,000USD£1,533GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1771EUR$2,000USD£1,533GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1771EUR$2,000USD£1,533GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1771EUR$2,000USD£1,533GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1771EUR$2,000USD£1,533GBP

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically.
The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer.
In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more